Sperm counts are declining worldwide at an accelerating rate, according to a recently published meta-analysis.
The 2017 study found that sperm counts had fallen in North America, Europe, and Australia by more than 50 percent in a 50-year span. The current study updated this data as well as added data from South and Central America, Asia, and Africa.
“The aim of this study was to examine trends in sperm count among men from all continents. The broader implications of a global decline in sperm count, the knowledge gaps left unfilled by our prior analysis, and the controversies surrounding this issue warranted an up-to-date meta-analysis,” the authors wrote.
The analysis found that sperm counts had declined at the average rate per year of 1.16 percent between 1972 and 2000. Since 2000, the rate of decline has increased significantly.

“We can say that our finding of a significant decline in sperm concentration and count is worldwide—that was a big change from the 2017 paper,” she said.
The Role of Plastics in Reproductive Disruption
The obvious question is—why the accelerated rate of decline?Swan dismissed genetic explanations, pointing out that genetic changes take “many generations to appear” while the noted changes are taking place in two generations or less.
“That leaves us with environment,” she said.
Swan and other experts believe that the problem is a class of chemicals called endocrine disruptors, which interfere with the body’s hormones.
These endocrine disruptors are found in many everyday products, including plastic bottles and containers, liners of metal food cans, detergents, flame retardants, food, toys, receipts from ATMs, and pesticides.
Phthalates, commonly found in personal care products, plastics, and children’s toys, are one common class of these compounds. They’re hard for consumers to avoid, particularly since manufacturers are under no obligation to identify these chemical ingredients.
Also, many of these disruptors are slow to break down in the environment, making them a long-term hazard.
One particular area of concern for researchers is reproduction, as these disruptors can interfere with fetal maturation and sexual differentiation in early pregnancy.
In the YouTube video, Swan illustrates how these disruptors can short-circuit testosterone production in the male fetus and lead to biological changes.
“There’s the male fetus developing around the first couple weeks of the first trimester: The genetic signal is for the testicles to develop and start making testosterone, and here comes this foreign influence from phthalates telling the body, well, you don’t need to make as much testosterone [because] we got it covered as they occupy the spaces ... of the androgen receptors, the testosterone receptors,” she said.
“They sit there and they say: ‘Okay we’re good here—you don’t need to make any more [testosterone].’ So the body says: ‘Okay—it won’t make any more’ ... and the boy will be under-masculinized.”
Criticism of Sperm Count Analysis
The 2017 study by Swan and her colleagues was criticized in an article published in the journal Human Fertility in May 2021 by researchers at Harvard’s GenderSci Lab. The researchers didn’t conduct their own detailed meta-analysis of sperm studies but criticized the assumptions and conclusions of the original research.The GenderSci authors argue that rather than concluding the results support a “sperm count decline” hypothesis, they propose “the sperm count biovariability” (SCB) hypothesis:
“SCB asserts that sperm count varies within a wide range, much of which can be considered non-pathological and species-typical. Knowledge about the relationship between individual and population sperm count and life-historical and ecological [i.e., regional] factors is critical to interpreting trends in average sperm counts and their relationships to health and fertility.”
The Health Consequences of Low Sperm Count
In contrast to the GenderSci Lab’s science-as-culture analysis, a study in Italy conducted by endocrinologists found that low sperm count was associated with metabolic alterations, cardiovascular risk, and low bone mass, according to lead author Dr. Alberto Ferlin, an associate professor of endocrinology at the University of Brescia.“Infertile men are likely to have important co-existing health problems or risk factors that can impair quality of life and shorten their lives,” said Ferlin, who’s also president of the Italian Society of Andrology and Sexual Medicine. “Fertility evaluation gives men the unique opportunity for health assessment and disease prevention.”
Specifically, Ferlin and his colleagues found that about half the men had low sperm counts and were 1.2 times more likely than those with normal sperm counts to have greater body fat (bigger waistline and higher body mass index; higher blood pressure (systolic, or top reading), “bad” (LDL) cholesterol and triglycerides; and lower “good” (HDL) cholesterol.
Low sperm count was defined as less than 39 million per ejaculate. All the men in the study had a sperm analysis as part of a comprehensive health evaluation in the university’s fertility clinic, which included measurement of their reproductive hormones and metabolic parameters.
They also had a higher frequency of metabolic syndrome, a cluster of these and other metabolic risk factors that increase the chance of developing diabetes, heart disease, and stroke, the investigators reported. A measure of insulin resistance, another problem that can lead to diabetes, also was higher in men with low sperm counts.